ZA977957B - Pharmacologically active compounds and use. - Google Patents
Pharmacologically active compounds and use.Info
- Publication number
- ZA977957B ZA977957B ZA9707957A ZA977957A ZA977957B ZA 977957 B ZA977957 B ZA 977957B ZA 9707957 A ZA9707957 A ZA 9707957A ZA 977957 A ZA977957 A ZA 977957A ZA 977957 B ZA977957 B ZA 977957B
- Authority
- ZA
- South Africa
- Prior art keywords
- active compounds
- pharmacologically active
- pharmacologically
- compounds
- active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/06—Six-membered rings
- C07D327/08—[b,e]-condensed with two six-membered carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2595696P | 1996-09-11 | 1996-09-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA977957B true ZA977957B (en) | 1998-04-16 |
Family
ID=21829002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9707957A ZA977957B (en) | 1996-09-11 | 1997-09-04 | Pharmacologically active compounds and use. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6110961A (xx) |
| EP (1) | EP1021434A2 (xx) |
| JP (1) | JP2002501475A (xx) |
| AU (1) | AU5531798A (xx) |
| CA (1) | CA2265943A1 (xx) |
| WO (1) | WO1998012190A2 (xx) |
| ZA (1) | ZA977957B (xx) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003104953A (ja) * | 2001-07-25 | 2003-04-09 | Showa Denko Kk | 有機金属錯体化合物および該化合物を用いたカルボン酸エステル製造方法 |
| CA2656767A1 (en) | 2006-07-07 | 2008-01-17 | Cenerx Biopharma, Inc. | Polymorphic form of fluoro-7-(2,2,2-trifluoroethoxy) phenoxathiin-10,10-dioxide |
| WO2010080977A2 (en) * | 2009-01-09 | 2010-07-15 | Cenerx Biopharma, Inc. | Oral sustained release antidepressant formulation |
| US20120003303A1 (en) * | 2009-01-09 | 2012-01-05 | Cenerx Biopharma, Inc | Oral enteric antidepressant formulation |
| WO2011096953A1 (en) * | 2010-02-05 | 2011-08-11 | Cenerx Biopharma, Inc. | Oral antidepressant formulation with reduced excipient load |
| US10414989B2 (en) * | 2016-04-15 | 2019-09-17 | Baker Hughes, A Ge Company, Llc | Chemical process for sulfur reduction of hydrocarbons |
| JP6836780B2 (ja) * | 2017-01-18 | 2021-03-03 | 国立大学法人 名古屋工業大学 | テトラフルオロベンゾオキサチアン化合物およびその製造方法 |
| AU2023383549A1 (en) | 2022-11-17 | 2025-06-05 | Remedi, Inc. | Combinations of monoamine oxidase inhibitors and serotonin receptor agonists and their therapeutic use |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3409636A (en) * | 1966-05-31 | 1968-11-05 | Dow Chemical Co | Alkyl phenoxathinium compounds |
| US3440249A (en) * | 1966-07-05 | 1969-04-22 | Dow Chemical Co | Aryl phenoxathiinium compounds |
| US3642997A (en) * | 1969-06-25 | 1972-02-15 | Merck & Co Inc | Tricyclic carboxylic acids in the treatment of inflammation |
| US4025635A (en) * | 1972-09-06 | 1977-05-24 | Burroughs Wellcome Co. | Cyclic sulphur compounds |
| EP0150891A1 (en) * | 1984-01-05 | 1985-08-07 | The Wellcome Foundation Limited | Tricyclic compounds, processes for their preparation, compositions containing such compounds and their use in medicine |
| GB8921069D0 (en) * | 1989-09-18 | 1989-11-01 | Wellcome Found | Pharmaceutically active compound,preparation and use |
| WO1992004897A1 (en) * | 1990-09-17 | 1992-04-02 | The Wellcome Foundation Limited | 1-substituted phenoxathiin derivatives as antidepressants |
| FR2768338B1 (fr) * | 1997-09-17 | 1999-10-15 | Synthelabo | Compositions pharmaceutiques contenant un inhibiteur de la monoamine oxydase et leur application en therapeutique |
-
1997
- 1997-08-19 JP JP51503298A patent/JP2002501475A/ja active Pending
- 1997-08-19 WO PCT/US1997/023486 patent/WO1998012190A2/en not_active Ceased
- 1997-08-19 AU AU55317/98A patent/AU5531798A/en not_active Abandoned
- 1997-08-19 EP EP97951761A patent/EP1021434A2/en not_active Withdrawn
- 1997-08-19 US US09/254,803 patent/US6110961A/en not_active Expired - Lifetime
- 1997-08-19 CA CA002265943A patent/CA2265943A1/en not_active Abandoned
- 1997-09-04 ZA ZA9707957A patent/ZA977957B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1021434A2 (en) | 2000-07-26 |
| WO1998012190A3 (en) | 1998-06-25 |
| AU5531798A (en) | 1998-04-14 |
| JP2002501475A (ja) | 2002-01-15 |
| WO1998012190A2 (en) | 1998-03-26 |
| US6110961A (en) | 2000-08-29 |
| CA2265943A1 (en) | 1998-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL137346A0 (en) | Pharmaceutically active morpholinol | |
| IL127559A0 (en) | Compounds and methods for providing pharmacologically active preparations and uses thereof | |
| ZA9711029B (en) | Therapeutic agents. | |
| ZA991951B (en) | Compound and its use. | |
| AU7908098A (en) | Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones | |
| ZA976222B (en) | N-(4-aryl-thiazol-2-yl)-sulphonamide derivatives and their use. | |
| ZA977807B (en) | New pharmaceutically active compounds. | |
| ZA977957B (en) | Pharmacologically active compounds and use. | |
| ZA977809B (en) | New pharmaceutically active compounds. | |
| ZA9711047B (en) | Formulation and use. | |
| GB9603431D0 (en) | Immunodulating active substance | |
| ZA977808B (en) | New pharmaceutically active compounds. | |
| ZA989312B (en) | Novel pharmaceutically active compounds, their preparation and use. | |
| ZA978469B (en) | New pharmaceutically active compounds. | |
| PL316604A1 (en) | Active self-extinguising line | |
| GB9602667D0 (en) | Pharmaceutically active compounds | |
| GB9610474D0 (en) | Pharmaceutically active compounds | |
| GB9602668D0 (en) | Pharmaceutically active compounds | |
| GB9619122D0 (en) | Pharmaceutically active compounds | |
| GB9618487D0 (en) | Pharmaceutically active compounds | |
| GB9616477D0 (en) | Pharmaceutically active compounds | |
| GB9614386D0 (en) | Pharmaceutically active compounds | |
| GB9614385D0 (en) | Pharmaceutically active compounds | |
| GB9610892D0 (en) | Pharmaceutically active compounds | |
| GB9610499D0 (en) | Pharmaceutically active compounds |